MetaCap

Compass Therapeutics Statistics

NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.6882+0.0097 (+1.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Compass Therapeutics by the numbers

Compass Therapeutics has a market capitalization of $123.9 million based on 180.09M shares outstanding. With trailing EPS of $-0.46, Compass Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.1% below its 50-day average and 75.3% below its 200-day average.

Average daily trading volume is 3.88M shares, or about $2.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CMPX valuation vs. peer median

CMPX compared with the median of 8 peer companies
MetricCMPXPeer medianDifference
Market cap$123.94M$119.31M+4%
Avg. volume3.88M1.16M+235%

Peer median across 8 companies: IVVD, HUMA, ENGN, ARMP, FATE, CRDL, TARA, STRO.

Valuation

Price and trading

Previous close
0.6785
Open
0.6711
Day range
0.6405 – 0.7297
52-week range
0.57 – 6.88
52-week change
-85.87%
Beta
—
Volume
1.82M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
123.94M
Forward Pe
-1.17
Eps
-0.46
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
6.88
Week52 Low
0.57
Avg Volume
3.88M
Shares Outstanding
180.09M
Ma50
0.98
Ma200
2.78
Earnings Date
Nov 9, 2026
Pct From52w High
-90.00%
Pct From52w Low
20.74%

Related